Robert Bartlett

846 total citations
12 papers, 672 citations indexed

About

Robert Bartlett is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Robert Bartlett has authored 12 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Oncology. Recurrent topics in Robert Bartlett's work include T-cell and B-cell Immunology (3 papers), Ocular Infections and Treatments (2 papers) and Immunotherapy and Immune Responses (2 papers). Robert Bartlett is often cited by papers focused on T-cell and B-cell Immunology (3 papers), Ocular Infections and Treatments (2 papers) and Immunotherapy and Immune Responses (2 papers). Robert Bartlett collaborates with scholars based in Germany, United States and Hungary. Robert Bartlett's co-authors include R. Schleyerbach, Martin Röllinghoff, Conny Hardt, Hermann Wagner, Alison Finnegan, Eric G. Bremer, Klaus Heeg, Werner Solbach, Klaus Pfizenmaier and Hubertus Stockinger and has published in prestigious journals such as FEBS Letters, Immunological Reviews and European Journal of Medicinal Chemistry.

In The Last Decade

Robert Bartlett

12 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Bartlett Germany 10 283 180 101 84 80 12 672
Susanne M. Scesney United States 14 405 1.4× 201 1.1× 87 0.9× 58 0.7× 74 0.9× 17 760
Daniela Metz United States 12 499 1.8× 108 0.6× 88 0.9× 109 1.3× 71 0.9× 16 911
Pernilla Lindahl France 9 526 1.9× 144 0.8× 232 2.3× 121 1.4× 46 0.6× 10 821
Daniel L. Kisner United States 13 173 0.6× 284 1.6× 221 2.2× 113 1.3× 28 0.3× 32 928
Connie Clark United States 8 442 1.6× 151 0.8× 116 1.1× 71 0.8× 25 0.3× 18 767
James L. Mobley United States 12 246 0.9× 152 0.8× 83 0.8× 33 0.4× 47 0.6× 18 504
R.J. Hartzman United States 11 406 1.4× 123 0.7× 61 0.6× 71 0.8× 45 0.6× 21 658
Jennifer Barks United States 10 304 1.1× 192 1.1× 184 1.8× 141 1.7× 216 2.7× 10 952
J. Leikola Finland 14 234 0.8× 271 1.5× 89 0.9× 136 1.6× 31 0.4× 48 898
Parvin Merryman United States 14 378 1.3× 123 0.7× 61 0.6× 37 0.4× 198 2.5× 19 759

Countries citing papers authored by Robert Bartlett

Since Specialization
Citations

This map shows the geographic impact of Robert Bartlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bartlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bartlett more than expected).

Fields of papers citing papers by Robert Bartlett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Bartlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bartlett. The network helps show where Robert Bartlett may publish in the future.

Co-authorship network of co-authors of Robert Bartlett

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Bartlett. A scholar is included among the top collaborators of Robert Bartlett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Bartlett. Robert Bartlett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Kosec, Duško, et al.. (1995). Leflunomide prevents the development of experimentally induced myasthenia gravis. International Journal of Immunopharmacology. 17(4). 273–281. 34 indexed citations
3.
Pfeifer, Sibylle, et al.. (1994). Beryllium-Induced Disturbances of the Murine Immune System Reflect Some Phenomena Observed in Sarcoidosis. International Archives of Allergy and Immunology. 104(4). 332–339. 4 indexed citations
4.
Coupland, Sarah E., et al.. (1994). Leflunomide therapy following penetrating keratoplasty in the rat. Graefe s Archive for Clinical and Experimental Ophthalmology. 232(10). 622–627. 6 indexed citations
5.
Bartlett, Robert, et al.. (1993). Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide. FEBS Letters. 334(2). 161–164. 136 indexed citations
6.
Mikecz, Katalin, Robert Bartlett, F. Deák, et al.. (1992). Immunomodulation of proteoglycan-induced progressive polyarthritis by lefluflomide. Immunopharmacology. 23(2). 105–116. 32 indexed citations
7.
Bartlett, Robert, et al.. (1989). Synthesis of basic substituted pyridines: a new class of antiasthmatic-antiallergic agents. European Journal of Medicinal Chemistry. 24(3). 227–232. 11 indexed citations
8.
9.
Bartlett, Robert & R. Schleyerbach. (1985). Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity — I. Disease modifying action on adjuvant arthritis of the rat. International Journal of Immunopharmacology. 7(1). 7–18. 99 indexed citations
10.
Limbert, M., Robert Bartlett, Gerhard Dickneite, et al.. (1984). Cefodizime, an aminothiazolyl cephalosporin. IV. Influence on the immune system.. The Journal of Antibiotics. 37(12). 1719–1726. 29 indexed citations
11.
Wagner, Hermann, et al.. (1981). Impact of Thymus on the Generation of Immunocompetence and Diversity of Antigen‐Specific MHC‐Restricted Cytotoxic T‐Lymphocyte Precursors. Immunological Reviews. 58(1). 95–129. 57 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne M. Scesney Breakdown of academic impact, for papers by Daniela Metz Breakdown of academic impact, for papers by Pernilla Lindahl Breakdown of academic impact, for papers by Daniel L. Kisner Breakdown of academic impact, for papers by Connie Clark Breakdown of academic impact, for papers by James L. Mobley Breakdown of academic impact, for papers by R.J. Hartzman Breakdown of academic impact, for papers by Jennifer Barks Breakdown of academic impact, for papers by J. Leikola Breakdown of academic impact, for papers by Parvin Merryman
Rankless by CCL
2026